Ascensia Diabetes Care announced today that it launched its online diabetes management and analytics platform in the U.S. Parsippany, New Jersey-based Ascensia now offers GlucoContro.online in more than 15 countries around the world. It plans for further expansion, too. Get the full story at our sister site, Drug Delivery Business News.
Big Data
iRhythm stock dives on reduced full-year guidance
iRhythm Technologies (Nasdaq:IRTC) shares took a hit after hours today on mixed third-quarter results that compared to the consensus forecast. Shares of IRTC nosedived 17.1% to $105.09 apiece after the market closed. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day up 2.1%. (UPDATE: After […]
What does the future hold for AI in medical devices?
Digital health, artificial intelligence (AI), machine learning and more — these concepts continue to generate buzz in the medtech world. Last month, the FDA published guidance on clinical decision support (CDS) software. It helped to clear up what constitutes a medical device and what doesn’t. Early last year, the agency published a predetermined change control […]
BD, Biocorp partner on connectivity for self-administered injectable drugs
BD (NYSE:BDX) announced that it entered into an agreement with Biocorp with the aim to use connected technology with injectable drugs. The companies seek to track adherence for self-administered drug therapies, including biologics. They plan to integrate France-based Biocorp’s Injay technology with BD’s UltraSafe Plus passive needle guard. Biocorp designed Injay to capture and transmit […]
Medtronic launches diabetes insights program for MiniMed users
Medtronic (NYSE:MDT) announced today that it introduced a new diabetes management program for users of the MiniMed 770G insulin pump. The medtech giant calls the new program My Insights. It designed it exclusively for individuals using the MiniMed 770G hybrid closed-loop insulin delivery system. Get the full story at our sister site, Drug Delivery Business […]
Digital health funding hits a low
Rock Health analysts say the third quarter of 2022 brought low funding numbers that raise questions about the condition of the digital health market. The report tallies digital health funding at $2.2 billion across 125 deals in the third quarter. This represents the smallest funding quarter in the sector for all of 2022. On top […]
7 innovative digital health offerings to treat diabetes
From using your smartphone to track data to reversing your diabetes altogether, these digital health technologies stand out. Advances in treatments for diabetes never stop coming. Whether that be in the form of insulin pumps or continuous glucose monitors, we’ve seen plenty. Moving away from the physical device, innovations in the digital diabetes space continue […]
NIH grants Eko $2.7M to develop pulmonary hypertension AI tech
Eko announced today that it received a $2.7 million Small Business Innovation Research (SBIR) Direct Phase II grant. The National Institutes of Health’s (NIH) Department of Health and Human Services (HHS) awarded the grant. The grant will fund the development of a machine learning algorithm, according to a news release. Eko said the algorithm detects […]
Verily receives $1B investment led by Alphabet, promotes president to corner office
Google’s (NSDQ:GOOGL) Verily announced today that it received a $1 billion investment led by parent company Alphabet. South San Francisco, California-based Verily plans to use the funds to expand its businesses focused on precision health. New capital will go toward a variety of its core initiatives. Those include real-world evidence generation, healthcare data, research and […]
FDA clears syringe infusion pump with Dose IQ software from Baxter
Baxter (NYSE:BAX) announced today that the FDA issued 510(k) clearance to its Novum IQ infusion pump with Dose IQ safety software. Deerfield, Illinois-based Baxter designed its new Novum IQ syringe infusion pump (SYR) to deliver small amounts of fluid at low rates. It includes a technologically integrated user experience with enhanced safety features. The system offers […]
PhysIQ, InCarda Therapeutics to collaborate on AFib treatment tech
PhysIQ announced today that it entered into a strategic collaboration with InCarda Therapeutics. Newark, California–based InCarda Therapeutics develops first-of-their-kind inhaled therapies for treating cardiovascular diseases. According to a news release, Syneos Health recommended PhysIQ’s patient monitoring technology to help advance InCarda’s clinical study of InRhythm (orally inhaled flecainide) in patients with AFib. The Phase III […]